This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn which Robo Advisor Supports Dividend Aristocrats Etf and compare options to choose the best fit for your dividend-focused strategy.
22,552 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
Intel stock has surged on AI optimism and cost discipline. This article explains the drivers behind the rally, the ri...
Bitcoin dipped under $63,000 as oil markets steadied and shipping through the Strait of Hormuz resumed. The move come...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
Pacs Group stock surged after the healthcare facility operator released solid quarterly results. Strong revenue growt...
A single year's price move and a wave of AI demand have rewritten the memory market narrative. This article explains ...
Savers face a rate tug-of-war in 2026 as money market accounts high yields compete with high yield savings accounts. ...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...